Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00012337
Status:
COMPLETED
Last Update Posted:
2013-06-24
First Post:
2001-03-03
Brief Title:
ZD 1839 in Treating Patients With Metastatic Kidney Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
A Trial of ZD1839 Iressa in Patients With Advanced Renal Cell Carcinoma
Status:
COMPLETED
Status Verified Date:
2002-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Some tumors need growth factors produced by the bodys white blood cells to keep growing Drugs such as ZD 1839 may interfere with the growth factors and cause tumor cells to die
PURPOSE Phase II trial to study the effectiveness of ZD 1839 in treating patients who have metastatic kidney cancer
PURPOSE Phase II trial to study the effectiveness of ZD 1839 in treating patients who have metastatic kidney cancer
Detailed Description:
OBJECTIVES I Determine the efficacy of ZD 1839 in patients with metastatic renal cell cancer II Determine the time to disease progression in patients treated with this drug III Determine the safety of this drug in these patients
OUTLINE Patients receive oral ZD 1839 once daily Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity Patients are followed for at least 1 month
PROJECTED ACCRUAL A total of 16-46 patients will be accrued for this study within 1 year
OUTLINE Patients receive oral ZD 1839 once daily Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity Patients are followed for at least 1 month
PROJECTED ACCRUAL A total of 16-46 patients will be accrued for this study within 1 year
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-1373 | None | None | None |
| MSKCC-00125 | None | None | None |